๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Subtype Selective NMDA Antagonists for the Treatment of Neurological Disease

โœ Scribed by S. Donevan

Book ID
109105494
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
5 KB
Volume
5
Category
Article
ISSN
1080-563X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The NMDA receptor antagonist memantine a
The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence
โœ Wojciech Danysz; Chris G. Parsons ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 407 KB ๐Ÿ‘ 1 views

There is increasing evidence for the involvement of glutamate-mediated neurotoxicity in the pathogenesis of Alzheimer's disease (AD). We suggest that glutamate receptors of the N-methyl-D-aspartate (NMDA) type are overactivated in a tonic rather than a phasic manner in this disorder. This continuous

Discovery of MK-7246, a selective CRTH2
Discovery of MK-7246, a selective CRTH2 antagonist for the treatment of respiratory diseases
โœ Michel Gallant; Christian Beaulieu; Carl Berthelette; John Colucci; Michael A. C ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 567 KB

In this manuscript we wish to report the discovery of MK-7246 (4), a potent and selective CRTH2 (DP2) antagonist. SAR studies leading to MK-7246 along with two synthetic sequences enabling the preparation of this novel class of CRTH2 antagonist are reported. Finally, the pharmacokinetic and metaboli